{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:20:52Z","timestamp":1788524452282,"version":"build-2803163510"},"reference-count":65,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["CJASN"],"abstract":"<jats:p>Women with CKD have a high burden of cardiovascular disease (CVD), yet cardiovascular phenotypes and outcomes differ from men because of both biologic factors and care processes. Heart failure is common in CKD; women more often present with heart failure with preserved ejection fraction and concentric remodeling driven by hypertension, arterial stiffness, inflammation, and microvascular dysfunction, whereas men more commonly demonstrate ischemic substrates and systolic dysfunction, heart failure with reduced ejection fraction. Women tend to have fewer obstructive coronary events but more ischemic symptoms without epicardial obstruction, consistent with microvascular dysfunction compounded by CKD-related endothelial impairment. Although women generally show lower predialysis CVD mortality than men, relative risk rises sharply with declining eGFR and albuminuria and the female survival advantage narrows on dialysis, where women may have more heart failure and stroke hospitalizations despite slightly lower cardiovascular mortality. Female-specific exposures including hypertensive disorders of pregnancy and the reproductive transition such as menarche, menstrual cycles, and menopause, further shape life-long cardio\u2013kidney risk trajectories. Despite proven benefits of blood pressure control, statins, renin\u2013angiotensin\u2013aldosterone system blockade, mineralocorticoid antagonists, and sodium-glucose cotransporter 2 inhibitors with emerging roles for incretin-based therapies, women remain undertreated and underrepresented in CKD and cardio\u2013renal trials. Priorities include consistent sex-disaggregated reporting, improved heart failure phenotyping in CKD, mechanistic study of vascular dysfunction across CKD progression, and implementation strategies to close sex gaps in evidence-based cardio\u2013renal care. This narrative review summarizes sex-based differences across CKD stages and kidney failure in CVD, vascular dysfunction, and therapeutic evidence gaps.<\/jats:p>","DOI":"10.2215\/cjn.0000001167","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T16:01:38Z","timestamp":1785513698000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Sex and Cardiovascular Outcomes with CKD"],"prefix":"10.2215","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9941-9404","authenticated-orcid":false,"given":"Silvi","family":"Shah","sequence":"first","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4942-0762","authenticated-orcid":false,"given":"Ester S.","family":"Oh","sequence":"additional","affiliation":[{"name":"Division of Renal Diseases and Hypertension, University of Colorado Anschutz Medical Campus, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1232-4849","authenticated-orcid":false,"given":"Preethi","family":"Yerram","sequence":"additional","affiliation":[{"name":"Nephrology Section, Harry S Truman VA Hospital, Columbia, Missouri"},{"name":"Division of Nephrology, Department of Medicine, University of Missouri, Columbia, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anum S.","family":"Minhas","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"issue":"10518","key":"B1-20260904","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/S0140-6736(25)01853-7","article-title":"Global, regional, and national burden of chronic kidney disease in adults, 1990-2023, and its attributable risk factors: a systematic analysis for the global burden of disease study 2023","volume":"406","author":"Mark","year":"2025","journal-title":"Lancet."},{"issue":"3","key":"B2-20260904","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nrneph.2017.181","article-title":"Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease","volume":"14","author":"Carrero","year":"2018","journal-title":"Nat Rev Nephrol."},{"issue":"11","key":"B3-20260904","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.120.050686","article-title":"Cardiovascular disease in chronic kidney disease: pathophysiological insights and therapeutic options","volume":"143","author":"Jankowski","year":"2021","journal-title":"Circulation."},{"issue":"2","key":"B4-20260904","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1053\/j.ajkd.2021.01.020","article-title":"Sex differences in cardiovascular outcomes in CKD: findings from the CRIC study","volume":"78","author":"Toth-Manikowski","year":"2021","journal-title":"Am J Kidney Dis."},{"issue":"12","key":"B5-20260904","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1093\/ckj\/sfad088","article-title":"The impact of gender on the risk of cardiovascular events in older adults with advanced chronic kidney disease","volume":"16","author":"Astley","year":"2023","journal-title":"Clin Kidney J."},{"issue":"10292","key":"B6-20260904","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1016\/S0140-6736(21)00684-X","article-title":"The lancet women and cardiovascular disease commission: reducing the global burden by 2030","volume":"397","author":"Vogel","year":"2021","journal-title":"Lancet."},{"key":"B7-20260904","doi-asserted-by":"crossref","first-page":"17455057221140209","DOI":"10.1177\/17455057221140209","article-title":"Sex differences in heart failure with preserved ejection fraction: from traditional risk factors to sex-specific risk factors","volume":"18","author":"Kaur","year":"2022","journal-title":"Womens Health (Lond)."},{"issue":"6","key":"B8-20260904","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jchf.2019.03.011","article-title":"Sex-based differences in heart failure across the ejection fraction spectrum: phenotyping, and prognostic and therapeutic implications","volume":"7","author":"Stolfo","year":"2019","journal-title":"JACC Heart Fail."},{"issue":"1","key":"B9-20260904","doi-asserted-by":"crossref","first-page":"F33","DOI":"10.1152\/ajprenal.00156.2020","article-title":"Sex differences in endothelial function in chronic kidney disease","volume":"319","author":"Kruse","year":"2020","journal-title":"Am J Physiol Renal Physiol."},{"issue":"9","key":"B10-20260904","doi-asserted-by":"crossref","first-page":"e029691","DOI":"10.1161\/JAHA.123.029691","article-title":"Sex differences in cardiovascular outcomes in patients with kidney failure","volume":"13","author":"Shah","year":"2024","journal-title":"J Am Heart Assoc."},{"issue":"17","key":"B11-20260904","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.jacc.2009.04.098","article-title":"Women and ischemic heart disease: evolving knowledge","volume":"54","author":"Shaw","year":"2009","journal-title":"J Am Coll Cardiol."},{"issue":"14","key":"B12-20260904","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.jacc.2019.08.1017","article-title":"Chronic kidney disease and coronary artery disease: JACC state-of-the-art review","volume":"74","author":"Sarnak","year":"2019","journal-title":"J Am Coll Cardiol."},{"issue":"24","key":"B13-20260904","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1093\/eurheartj\/ehy060","article-title":"Chronic kidney disease and arrhythmias: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference","volume":"39","author":"Turakhia","year":"2018","journal-title":"Eur Heart J."},{"issue":"1","key":"B14-20260904","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1186\/s12872-021-02419-2","article-title":"Sex differences in treatment strategy and adverse outcomes among patients 75 and older with atrial fibrillation in the MarketScan database","volume":"21","author":"Subramanya","year":"2021","journal-title":"BMC Cardiovasc Disord."},{"issue":"17","key":"B15-20260904","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/eurjpc\/zwaf050","article-title":"Sex differences in cardiovascular-kidney-metabolic risk factors associated with degenerative valvular heart disease","volume":"32","author":"Yang","year":"2025","journal-title":"Eur J Prev Cardiol."},{"issue":"3 suppl 1","key":"B16-20260904","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2016.12.004","article-title":"US renal data system 2016 annual data report: epidemiology of kidney disease in the United States","volume":"69","author":"Saran","year":"2017","journal-title":"Am J Kidney Dis."},{"issue":"7","key":"B17-20260904","doi-asserted-by":"crossref","first-page":"e0254554","DOI":"10.1371\/journal.pone.0254554","article-title":"Relationship between sex and cardiovascular mortality in chronic kidney disease: a systematic review and meta-analysis","volume":"16","author":"Shajahan","year":"2021","journal-title":"PLoS One."},{"issue":"10","key":"B18-20260904","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.34067\/KID.0000000000000239","article-title":"Sex differences in cardiovascular and all-cause mortality in adults with and without CKD: NHANES 1999-2018","volume":"4","author":"Oh","year":"2023","journal-title":"Kidney360."},{"key":"B19-20260904","doi-asserted-by":"crossref","first-page":"F324","DOI":"10.1136\/bmj.f324","article-title":"Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis","volume":"346","author":"Nitsch","year":"2013","journal-title":"BMJ."},{"issue":"4","key":"B20-20260904","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1053\/j.ajkd.2013.04.010","article-title":"CKD and cardiovascular disease in the atherosclerosis risk in communities (ARIC) study: interactions with age, sex, and race","volume":"62","author":"Hui","year":"2013","journal-title":"Am J Kidney Dis."},{"issue":"9","key":"B21-20260904","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.amjcard.2007.12.030","article-title":"Usefulness of microalbuminuria versus the metabolic syndrome as a predictor of cardiovascular disease in women and men >40 years of age (from the Rancho Bernardo Study)","volume":"101","author":"Jassal","year":"2008","journal-title":"Am J Cardiol."},{"key":"B22-20260904","doi-asserted-by":"crossref","first-page":"1544590","DOI":"10.3389\/fcvm.2025.1544590","article-title":"Differential cardiovascular risk profiles by sex among adults with CKD: a NHANES-based analysis","volume":"12","author":"Belikoff","year":"2025","journal-title":"Front Cardiovasc Med."},{"issue":"11","key":"B23-20260904","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1093\/ndt\/gfm377","article-title":"Detection of coronary and peripheral artery calcification in patients with chronic kidney disease stages 3 and 4, with and without diabetes","volume":"22","author":"Porter","year":"2007","journal-title":"Nephrol Dial Transplant."},{"issue":"3","key":"B24-20260904","doi-asserted-by":"crossref","first-page":"sfaf034","DOI":"10.1093\/ckj\/sfaf034","article-title":"The hidden interplay between sex and adverse outcomes in incident dialysis patients: the role of aortic calcification","volume":"18","author":"Zhao","year":"2025","journal-title":"Clin Kidney J."},{"issue":"10","key":"B25-20260904","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1016\/j.ekir.2023.07.032","article-title":"Regional variation in hemoglobin distribution among individuals with CKD: the ISN International Network of CKD cohorts","volume":"8","author":"Canney","year":"2023","journal-title":"Kidney Int Rep."},{"issue":"1","key":"B26-20260904","doi-asserted-by":"crossref","first-page":"H135","DOI":"10.1152\/ajpheart.00908.2024","article-title":"Endothelial dysfunction in chronic kidney disease: a clinical perspective","volume":"329","author":"Cho","year":"2025","journal-title":"Am J Physiol Heart Circ Physiol."},{"issue":"11","key":"B27-20260904","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1093\/ndt\/gfr081","article-title":"Vascular health, systemic inflammation and progressive reduction in kidney function; clinical determinants and impact on cardiovascular outcomes","volume":"26","author":"Yilmaz","year":"2011","journal-title":"Nephrol Dial Transplant."},{"issue":"6","key":"B28-20260904","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1161\/HYPERTENSIONAHA.112.197210","article-title":"Large artery stiffening and remodeling are independently associated with all-cause mortality and cardiovascular events in chronic kidney disease","volume":"60","author":"Karras","year":"2012","journal-title":"Hypertension."},{"issue":"6","key":"B29-20260904","doi-asserted-by":"crossref","first-page":"H1130","DOI":"10.1152\/ajpheart.00500.2022","article-title":"Sex differences in microvascular function and arterial hemodynamics in nondialysis chronic kidney disease","volume":"323","author":"Kirkman","year":"2022","journal-title":"Am J Physiol Heart Circ Physiol."},{"issue":"1","key":"B30-20260904","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/hdi.12544","article-title":"Sex differences in vascular dysfunction and cardiovascular outcomes: the cardiac, endothelial function, and arterial stiffness in ESRD (CERES) study","volume":"22","author":"Guajardo","year":"2018","journal-title":"Hemodial Int."},{"issue":"4","key":"B31-20260904","doi-asserted-by":"crossref","first-page":"F661","DOI":"10.1152\/ajprenal.00308.2023","article-title":"Sex differences in sympathetic activity and pulse wave velocity in adults with chronic kidney disease","volume":"326","author":"Zanuzzi","year":"2024","journal-title":"Am J Physiol Renal Physiol."},{"issue":"3","key":"B32-20260904","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2215\/CJN.0000000922","article-title":"Sex differences in dementia and mild cognitive impairment in nondialysis CKD","volume":"21","author":"Oh","year":"2025","journal-title":"Clin J Am Soc Nephrol."},{"issue":"3","key":"B33-20260904","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1053\/j.ackd.2013.01.012","article-title":"Renal physiology of pregnancy","volume":"20","author":"Cheung","year":"2013","journal-title":"Adv Chronic Kidney Dis."},{"issue":"3","key":"B34-20260904","first-page":"345","article-title":"Hypertensive disorders of pregnancy","volume":"37","author":"Shah","year":"2019","journal-title":"Cardiol Clin."},{"issue":"10","key":"B35-20260904","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.34067\/KID.0000000000000228","article-title":"Evaluation and management of hypertensive disorders of pregnancy","volume":"4","author":"Bajpai","year":"2023","journal-title":"Kidney360."},{"issue":"8","key":"B36-20260904","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJMoa0706790","article-title":"Preeclampsia and the risk of end-stage renal disease","volume":"359","author":"Vikse","year":"2008","journal-title":"N Engl J Med."},{"issue":"6","key":"B37-20260904","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1053\/j.ajkd.2023.04.010","article-title":"Preeclampsia and long-term kidney outcomes: an observational cohort study","volume":"82","author":"Srialluri","year":"2023","journal-title":"Am J Kidney Dis."},{"issue":"12","key":"B38-20260904","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/jama.2021.14781","article-title":"Aspirin use to prevent preeclampsia and related morbidity and mortality: US preventive services task force recommendation statement","volume":"326","author":"Davidson","year":"2021","journal-title":"JAMA."},{"issue":"4","key":"B39-20260904","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s11897-022-00555-0","article-title":"Evaluation of the interaction of sex hormones and cardiovascular function and health","volume":"19","author":"Willemars","year":"2022","journal-title":"Curr Heart Fail Rep."},{"key":"B40-20260904","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.maturitas.2017.08.003","article-title":"Gaps, limitations and new insights on endogenous estrogen and follicle stimulating hormone as related to risk of cardiovascular disease in women traversing the menopause: a narrative review","volume":"104","author":"El Khoudary","year":"2017","journal-title":"Maturitas."},{"issue":"24","key":"B41-20260904","doi-asserted-by":"crossref","first-page":"e043102","DOI":"10.1161\/JAHA.125.043102","article-title":"Influence of chronic kidney disease on the relationship between menopausal status and major cardiovascular disease in women","volume":"14","author":"Han","year":"2025","journal-title":"J Am Heart Assoc."},{"issue":"7","key":"B42-20260904","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1001\/jamacardio.2016.2415","article-title":"Association of age at onset of menopause and time since onset of menopause with cardiovascular outcomes, intermediate vascular traits, and all-cause mortality: a systematic review and meta-analysis","volume":"1","author":"Muka","year":"2016","journal-title":"JAMA Cardiol."},{"issue":"8","key":"B43-20260904","doi-asserted-by":"crossref","first-page":"e003769","DOI":"10.1161\/JAHA.116.003769","article-title":"Association of age at menopause with incident heart failure: a prospective cohort study and meta-analysis","volume":"5","author":"Appiah","year":"2016","journal-title":"J Am Heart Assoc."},{"issue":"11","key":"B44-20260904","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.2215\/CJN.03990318","article-title":"CKD in patients with bilateral oophorectomy","volume":"13","author":"Kattah","year":"2018","journal-title":"Clin J Am Soc Nephrol."},{"key":"B45-20260904","doi-asserted-by":"crossref","first-page":"108595","DOI":"10.1016\/j.maturitas.2025.108595","article-title":"Menopause is associated with a reduction in glomerular filtration rate, independent of body composition and metabolic syndrome","volume":"198","author":"Leone","year":"2025","journal-title":"Maturitas."},{"key":"B46-20260904","doi-asserted-by":"crossref","first-page":"108145","DOI":"10.1016\/j.maturitas.2024.108145","article-title":"Chronic kidney disease and menopausal health: an EMAS clinical guide","volume":"192","author":"Cevik","year":"2025","journal-title":"Maturitas."},{"key":"B47-20260904","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/GME.0000000000002028","article-title":"The 2022 hormone therapy position statement of the North American Menopause society","volume":"29","year":"2022","journal-title":"Menopause."},{"issue":"5","key":"B48-20260904","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/MNH.0000000000001000","article-title":"Women's health and kidney protective medications","volume":"33","author":"Shankar","year":"2024","journal-title":"Curr Opin Nephrol Hypertens."},{"issue":"1","key":"B49-20260904","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.ajkd.2018.12.044","article-title":"Hypertension in CKD: Core Curriculum 2019","volume":"74","author":"Ku","year":"2019","journal-title":"Am J Kidney Dis."},{"issue":"22","key":"B50-20260904","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N Engl J Med."},{"issue":"3","key":"B51-20260904","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jchf.2019.01.009","article-title":"Adverse drug reactions to guideline-recommended heart failure drugs in women: a systematic review of the literature","volume":"7","author":"Bots","year":"2019","journal-title":"JACC Heart Fail."},{"issue":"8","key":"B52-20260904","doi-asserted-by":"crossref","first-page":"e005562","DOI":"10.1161\/CIRCOUTCOMES.118.005562","article-title":"Sex differences in the use of statins in community practice","volume":"12","author":"Nanna","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes."},{"issue":"20","key":"B53-20260904","doi-asserted-by":"crossref","first-page":"e043214","DOI":"10.1161\/JAHA.125.043214","article-title":"Effect of statins in patients with hemodialysis-dependent chronic kidney disease: a nationwide cohort study","volume":"14","author":"Baik","year":"2025","journal-title":"J Am Heart Assoc."},{"issue":"4","key":"B54-20260904","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jacl.2016.02.016","article-title":"Gender differences in side effects and attitudes regarding statin use in the Understanding Statin Use in America and Gaps in Patient Education (USAGE) study","volume":"10","author":"Karalis","year":"2016","journal-title":"J Clin Lipidol."},{"issue":"9","key":"B55-20260904","doi-asserted-by":"crossref","first-page":"e007045","DOI":"10.1161\/CIRCOUTCOMES.120.007045","article-title":"Sex, drugs, and adverse drug reactions: sex differences in laboratory monitoring outcomes after initiation of renin-angiotensin-aldosterone-system inhibition therapy","volume":"13","author":"Dumanski","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes."},{"issue":"3","key":"B56-20260904","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00125-024-06325-y","article-title":"Sex differences in the efficacy of angiotensin receptor blockers on kidney and cardiovascular outcomes among individuals with type 2 diabetes and diabetic kidney disease: post hoc analyses of the RENAAL and IDNT trials","volume":"68","author":"de Vries","year":"2025","journal-title":"Diabetologia."},{"issue":"3","key":"B57-20260904","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jchf.2019.01.003","article-title":"Sex differences in outcomes and responses to spironolactone in heart failure with preserved ejection fraction: a secondary analysis of TOPCAT trial","volume":"7","author":"Merrill","year":"2019","journal-title":"JACC Heart Fail."},{"issue":"23","key":"B58-20260904","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med."},{"issue":"2","key":"B59-20260904","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"388","author":"Herrington","year":"2023","journal-title":"N Engl J Med."},{"issue":"15","key":"B60-20260904","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med."},{"issue":"8","key":"B61-20260904","doi-asserted-by":"crossref","first-page":"100851","DOI":"10.1016\/j.xkme.2024.100851","article-title":"SGLT2 inhibitor use in chronic kidney disease: supporting cardiovascular, kidney, and metabolic health","volume":"6","author":"Madero","year":"2024","journal-title":"Kidney Med."},{"issue":"1","key":"B62-20260904","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1053\/j.ajkd.2024.08.002","article-title":"Glucagon-like peptide-1 receptor agonists: new evidence of kidney and cardiovascular protection from the FLOW and SELECT trials","volume":"85","author":"Taal","year":"2025","journal-title":"Am J Kidney Dis."},{"issue":"3","key":"B63-20260904","doi-asserted-by":"crossref","first-page":"e70063","DOI":"10.1111\/1753-0407.70063","article-title":"Sex differences in the efficacy of glucagon-like peptide-1 receptor agonists for weight reduction: a systematic review and meta-analysis","volume":"17","author":"Yang","year":"2025","journal-title":"J Diabetes."},{"key":"B64-20260904","first-page":"643822","article-title":"Sex differences in GLP-1 signaling across species","author":"Roseberry","year":"2017","journal-title":"bioRxiv."},{"issue":"9","key":"B65-20260904","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/ckj\/sfad018","article-title":"Women's representation in clinical trials of patients with chronic kidney disease","volume":"16","author":"Pinho-Gomes","year":"2023","journal-title":"Clin Kidney J."}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000001167","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T12:00:45Z","timestamp":1788523245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000001167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":65,"URL":"https:\/\/doi.org\/10.2215\/cjn.0000001167","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]}}}